SEC Form 4 · accession 0001144204-15-057282
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunil Bhonsle
Officer — President · Director
Period of report
Sep 28, 2015
Accepted (ET)
Sep 29, 2015 · 9:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 28, 2015 | P | 910 | $3.622 | A | 90,274 | D | |
| Common StockF1,F3 | holding | — | — | — | 54,684 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All share and dollar amounts reflect a 1-for-5.5 reverse stock split effected on 9/29/15.
- F2Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $3.58 to $3.63. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F3The reporting person serves as trustee of the family trust.